Shionogi & Co. Ltd. (4507.TO) Osaka Nine Months Ended December 31 GROUP 2025 2024 Revenue Y360.68 bln Y333.60 bln Operating Profit Y148.74 bln Y129.22 bln Pretax Profit Y191.27 bln Y155.88 bln Net ...

By Yadarisa Shabong Jan 20 (Reuters) - Britain's GSK and Japan's Shionogi said on Tuesday that Pfizer will exit their HIV ...

Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported on January 20 that Britain ...

Pfizer exits ViiV Healthcare with a $1.89bn payout, while GSK retains its majority stake amid the shareholder shake-up.

Jan 20 (Reuters) - Japan's Shionogi & Co said on Tuesday it would pay $2.13 billion for new shares in ViiV Healthcare, its ...

Japanese drugmaker company Shionogi & Co. will invest $2.1 billion to raise its stake in ViiV Healthcare to 21.7%, ...

Pfizer will relinquish its stake in ViiV Healthcare in a deal valued at just over $2.1 billion that ramps up Shionogi's ...

As a result of the acquisition, Pfizer will no longer hold shares of ViiV Healthcare Limited and Shionogi will see its holdings increase to 21.7%. 1 The majority shareholder of ViiV Healthcare Limited ...

The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...

The 11.7% economic interest in specialist HIV company ViiV Healthcare that is currently held by US pharma giant Pfizer is to ...

Jan 20 (Reuters) - Japan's Shionogi & Co said on Tuesday it would pay $2.13 billion for new shares in joint venture ViiV ...

Investing.com -- Japan’s Shionogi & Co (TYO:4507) said on Tuesday it would pay $2.13 billion for new shares in joint venture ViiV Healthcare, increasing its stake in the HIV drugmaker to 21.7% as U.S.